Stock Events

IGC Pharma 

$0.32
43
-$0-1.53% Today

Statistics

Day High
0.32
Day Low
0.3
52W High
0.49
52W Low
0.27
Volume
127,753
Avg. Volume
116,862
Mkt Cap
20.08M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12FebExpected
Q4 2021
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Next
-0.08
-0.07
-0.05
-0.04
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IGC. It's not an investment recommendation.

About

Biotechnology
Health Technology
Manufacturing
Medicinal and Botanical Manufacturing
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand. The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts. It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Show more...
CEO
Ram Mukunda
Employees
52
Country
US
ISIN
US45408X3089
WKN
000A1T87A

Listings